Long non-coding RNA maternally expressed gene 3, miR-125a-5p, CXCL13, and NF-kB in patients with immune thrombocytopenia
- PMID: 37045944
- PMCID: PMC10110462
- DOI: 10.1038/s41435-023-00200-3
Long non-coding RNA maternally expressed gene 3, miR-125a-5p, CXCL13, and NF-kB in patients with immune thrombocytopenia
Abstract
The main aim of this study was to assess the expression level of circulating long non-coding RNA maternally expressed gene 3 (lncRNA-MEG3), microRNA (miR-125a-5P), the chemokine C-X-C motif ligand13 (CXCL13), and the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB) in immune thrombocytopenia (ITP) cases and to study its relation to the disease severity and treatment response. This case-control study included 45 patients newly diagnosed as ITP and 45 healthy subjects. We assessed complete blood count, antinuclear antibodies, hepatitis B and C virus serology, lncRNA-MEG3, miR-125a-5P, and CXCL13 expression in serum by real-time PCR and NF-kb protein by ELISA. In ITP patients compared to control, lncRNA-MEG3 was significantly increased, and miRNA-125a-5P was decreased, and this was associated with higher CXCL13 and NF-kB levels (P < 0.001, for all).There was a significant negative correlation between platelet count and lncRNA-MEG3, CXCL13, and NF-kb, while a positive correlation with miR-125a-5p in ITP patients. Patients who responded to steroids had significantly higher miR-125a-5p (P = 0.016) and significantly lower lncRNA-MEG3 (P < 0.001), CXCL13 (P = 0.005), and NF-kb (p = 0.002). Based on the ROC curves, lncRNA-MEG3 displayed the highest area under the curve (AUC) in the identification of organ bleeding (AUC = 0.805), the response to steroids (AUC = 0.853), and the need for splenectomy (AUC = 0.75).
© 2023. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures


Similar articles
-
Long non-coding RNA MEG3 inhibits microRNA-125a-5p expression and induces immune imbalance of Treg/Th17 in immune thrombocytopenic purpura.Biomed Pharmacother. 2016 Oct;83:905-911. doi: 10.1016/j.biopha.2016.07.057. Epub 2016 Aug 10. Biomed Pharmacother. 2016. PMID: 27522004
-
LncRNA MEG3 Participates in Caerulein-Induced Inflammatory Injury in Human Pancreatic Cells via Regulating miR-195-5p/FGFR2 Axis and Inactivating NF-κB Pathway.Inflammation. 2021 Feb;44(1):160-173. doi: 10.1007/s10753-020-01318-6. Inflammation. 2021. PMID: 32856219
-
MEG3 alleviates ankylosing spondylitis by suppressing osteogenic differentiation of mesenchymal stem cells through regulating microRNA-125a-5p-mediated TNFAIP3.Apoptosis. 2023 Apr;28(3-4):498-513. doi: 10.1007/s10495-022-01804-2. Epub 2022 Dec 31. Apoptosis. 2023. PMID: 36587050
-
The lncRNA MEG3/miR-16-5p/VGLL4 regulatory axis is involved in etoposide-induced senescence of tumor cells.J Gene Med. 2021 Feb;23(2):e3291. doi: 10.1002/jgm.3291. Epub 2020 Dec 22. J Gene Med. 2021. PMID: 33141998
-
Interfering histone deacetylase 4 inhibits the proliferation of vascular smooth muscle cells via regulating MEG3/miR-125a-5p/IRF1.Cell Adh Migr. 2019 Dec;13(1):41-49. doi: 10.1080/19336918.2018.1506653. Epub 2018 Aug 29. Cell Adh Migr. 2019. PMID: 30156956 Free PMC article.
Cited by
-
LncRNA NEAT1 targets miR-125/ADAM9 mediated NF-κB pathway in inflammatory response of rosacea.Skin Res Technol. 2024 Jul;30(7):e13630. doi: 10.1111/srt.13630. Skin Res Technol. 2024. Retraction in: Skin Res Technol. 2025 Feb-May;31(2-5):e70185. doi: 10.1111/srt.70185. PMID: 38988131 Free PMC article. Retracted.
-
Predicting the efficacy of glucocorticoids in pediatric primary immune thrombocytopenia using plasma proteomics.Front Immunol. 2023 Dec 14;14:1301227. doi: 10.3389/fimmu.2023.1301227. eCollection 2023. Front Immunol. 2023. PMID: 38162645 Free PMC article.
-
Circulating miRNAs and childhood asthma ICS response: a stratified analysis in the intervention arm of an RCT with vitamin D effect modification.Thorax. 2025 Jun 4:thorax-2024-222618. doi: 10.1136/thorax-2024-222618. Online ahead of print. Thorax. 2025. PMID: 40467329
-
The intersection of epigenetics and immune thrombocytopenia: new insights into disease mechanisms and treatments.Mol Biol Rep. 2025 Feb 21;52(1):257. doi: 10.1007/s11033-025-10363-z. Mol Biol Rep. 2025. PMID: 39982580 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources